Suvorexant has shown teratogenic effects hinein animals such as decreased body weight at doses much higher than the equivalents of those approved for therapeutic use rein humans.[2][3] Teratogenic effects with therapeutic doses of suvorexant hinein humans have not been established due to lack of research and available data.[2][3] Suvorexant is preg